Interesting that despite the high levels of immune escape and antigenic divergence of both BQ.1* and XBB variants from other omicron variants & the growth being seen across the UK & US & other regions, neither has been designated a variant of concern by the UKHSA.
They meet the criteria:
-XBB & BQ.1* growth has been seen in multiple countries- Singapore, US, UK & others
-growth has co-incided with increase in cases & hosp
have shown very high immune evasion in neutralisation studies
-they are very divergent from previous variants
-XBB & BQ.1* growth has been seen in multiple countries- Singapore, US, UK & others
-growth has co-incided with increase in cases & hosp
have shown very high immune evasion in neutralisation studies
-they are very divergent from previous variants
So, why are they not being considered as VOCs, given their own names, and importantly reported as linked to pandemic growth in many countries. E.g. in the UK, you'd be forgiven for not even knowing that BQ.1* variants had been growing with growth coinciding with the current wave.
Honestly, what is the point of genomic surveillance, if no action is ever taken- not even the most simple action of public messaging to make people aware of the threat posed by virus evolution - which is continuing rapidly & threatening current vaccines.
In the US, these variants are dominant, and have been growing rapidly. Where is the reporting on this, and the messaging around this, given the threat posed to immune protection?
Loading suggestions...